Abstract
Get full access to this article
View all access options for this article.
References
1.
Compston
A
Coles
AJ
. Multiple sclerosis . Lancet
2002 ; 359 : 1221 –31 .
2.
Hyland
M
Rudick
RA
. Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs
Current Opinion in Neurology
2011 ; 24 : 255 –261 .
3.
Filippi
M
Agosta
F
. Imaging biomarkers in multiple sclerosis . J Magn Reson Imaging
2010 ; 31 : 770 –788 .
4.
Daumer
M
Neuhaus
A
Morrissey
S
. MRI as an outcome in multiple sclerosis clinical trials . Neurology
2009 ; 72 : 705 –711 .
5.
Moraal
B
Wattjes
MP
Geurts
JJ
. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging . Radiology
2010 ; 255 : 154 –163 .
6.
Jacobs
LD
Cookfair
DL
Rudick
RA
. A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG) . Mult Scler
1995 ; 1 : 118 –135 .
7.
Schwid
SR
Goodman
AD
Mattson
DH
. The measurement of ambulatory impairment in multiple sclerosis . Neurology
1997 ; 49 : 1419 –1424 .
8.
Tumani
H
Hartung
HP
Hemmer
B
. Cerebrospinal fluid biomarkers in multiple sclerosis . Neurobiol Dis
2009 ; 35 (2 ): 117 –127 .
9.
Evans
RW
Armon
C
Frohman
EM
. Assessment: prevention of postlumbar puncture headaches: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology . Neurology
2000 ; 55 : 909 –914 .
10.
Giovannoni
G
. Lumbar puncture for clinical trials in MS . http://multiple-sclerosis-research.blogspot.com/
11.
Strupp
M
Schueler
O
Straube
A
. Atraumatic Sprotte needle reduces the incidence of post-lumbar puncture headaches . Neurology
2001 ; 57 : 2310 –2312 .
12.
Peskind
ER
Riekse
R
Quinn
JF
. Safety and acceptability of the research lumbar puncture . Alzheimer Dis Assoc Disord
2005 ; 19 (4 ): 220 –225 .